1. Dalby MA. Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychornotor epilepsy. Epilepcia 1971;12: 325-334. [DOI:10.1111/j.1528-1157.1971.tb04380.x]

2. Meldrum BS, Porter RJ, Editors. Current problems in epilepsy: new anticonvulsant drugs. London: John Libbey; 1986.

3. Jain KK, Editor. Drug Delivery Systems. USA: Humana Press; 2008. [DOI:10.1007/978-1-59745-210-6]

4. Clara M, Strenn B, Kreuzinger N. Carbamazepine as a possible anthropogenic marker in the aquatic environment: Investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration. Water Res 2004;38: 947-954. [DOI:10.1016/j.watres.2003.10.058]

5. Schramm C, Gans O, Uhl M, Grath J, Scharf S, Zieritz I, et al, Editors. Carbamazepin Und Koffein‐Potenzielle Screeningparameter Fur Verunreingungen Des Grundwassers Durch Kommunales Abwasser. Wien: Umweltbundesamt; 2006.

6. Marino SE, Pakhomov SV, Han S, Anderson KL, Ding M, Eberly LE, et al. The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory. Epilepsy Behav 2012;24:365-72. [DOI:10.1016/j.yebeh.2012.04.120]

7. Katzhendler I, Azoury R, Friedman M. Crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets based on hydroxypropyl methylcellulose. J Control Release 1998;54:69-85. [DOI:10.1016/S0168-3659(98)00002-9]

8. Free patents online. Controlled release solid dosage Carbamazepine formulations - United States Patent 6572889. Avaiable from: https://patents.google.com/patent/US6572889B1/en.

9. Guneysel O, Onur O, Denizbasi A, Saritemur M. Carbamazepine overdose after exposure to simethicone: a case report. J Med Case Rep 2008;2:242. [DOI:10.1186/1752-1947-2-242]

10. Philip F. Builders 1 and Mathew I. Arhewoh2 Pharmaceutical applications of native starch in conventional drug delivery 68, 1-10 DOI 10.1002/star.201500337. September 2016 [DOI:10.1002/star.201500337]

11. Chein YW. Oral Drug delivery and delivery systems. In: Novel drug delivery systems. New York: Marcel Dekker Inc.; 2002.

12. Ali W, Badawi AA, Mahdy MA, El-Nahas HM. Formulation and Evaluation of Carbamazepine 200 mg Controlled Release Tablets Using Different HPMC Grades. J Pharm Res Int 2013;3:632-647. [DOI:10.9734/BJPR/2013/3923]

13. Ju R.T.C, Nixon P.R, Patel M.V, Tong D.M. Drug release from hydrophilic matrices. 2. Amathematical model based on the disentanglement concentration and the diffusion layer. J Pharm Sci 1995;84:1464-1477. [DOI:10.1002/jps.2600841214]

14. Nagar M. formulation and evaluation of carbamazepine extended release tablet by controlled erosion technologyinternational. J Pharm Sci 2012; 4:0975-1491.

15. Charulatha R, Rajan K. Design and Evaluation of Carbamazepine Controlled Release Drug Delivery System International. J PharmTech Res 2012;4: 0974-4304.

16. Goldensohn ES, Porter RJ, Schwartzkroin PA. The American Epilepsy Society: an historic perspective on 50 years of advances in research. Epilepsia 1997;38:124-50. [DOI:10.1111/j.1528-1157.1997.tb01088.x]